December 17, 2014
The Linked2Safety project, funded under the FP7 scheme of the European Commission, was launched to advance clinical practice and accelerate medical research by providing pharmaceutical companies, healthcare professionals and patients with an “innovative semantic interoperability framework, facilitating efficient and homogenised access to distributed Electronic Health Records (EHRs)”.
Electronic Health Records (EHRs) contain an increasing wealth of medical information and have the potential to signiﬁcantly advance medical research, as well as improve health policies. However, the European healthcare information space is fragmented due to the lack of legal and technical standards, cost effective platforms and sustainable business models. Linked2Safety is a platform for analysing EHRs from multiple institutions, while strictly adhering to the legal and ethical requirements deﬁned by each data provider at EU level.
Benefits for this 36-month Linked2Safety project include facilitating data analysis in EHRs, including genetic, environmental and medical histories of subjects exhibiting adverse events during clinical trials. This will help provide genotype-phenotype associations and a platform to identify and select patients for clinical trials by linking EHR repositories.